Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis J Goodman

Showing results (81-90 of 157) with videos related to

Pageof 16
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2010
Transition of a clinical trial into translational research: the prostate cancer prevention trial experiencePhyllis J Goodman, Catherine M Tangen, Alan R Kristal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 30, 2017
A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT CohortsElizabeth A Platz, Ibrahim Kulac, John R Barber, et al.
Journal of the National Cancer Institute|September 13, 2007
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention TrialM Scott Lucia, Jonathan I Epstein, Phyllis J Goodman, et al.
The New England Journal of Medicine|June 26, 2003
The influence of finasteride on the development of prostate cancerIan M Thompson, Phyllis J Goodman, Catherine M Tangen, et al.
Carcinogenesis|July 21, 2011
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Song Yao, Cathee Till, et al.
Carcinogenesis|December 12, 2017
Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Mary E Platek, Song Yao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2015
Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention TrialTeemu J Murtola, Bora Gurel, Martin Umbehr, et al.
The Journal of Urology|October 19, 2010
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trialDouglas K Price, Cindy H Chau, Cathee Till, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2012
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasterideAlan R Kristal, Cathee Till, Catherine M Tangen, et al.
Pageof 16

Showing results (81-90 of 157) with videos related to

Sort By:
Pageof 16
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2010
Transition of a clinical trial into translational research: the prostate cancer prevention trial experiencePhyllis J Goodman, Catherine M Tangen, Alan R Kristal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 30, 2017
A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT CohortsElizabeth A Platz, Ibrahim Kulac, John R Barber, et al.
Journal of the National Cancer Institute|September 13, 2007
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention TrialM Scott Lucia, Jonathan I Epstein, Phyllis J Goodman, et al.
The New England Journal of Medicine|June 26, 2003
The influence of finasteride on the development of prostate cancerIan M Thompson, Phyllis J Goodman, Catherine M Tangen, et al.
Carcinogenesis|July 21, 2011
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Song Yao, Cathee Till, et al.
Carcinogenesis|December 12, 2017
Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Mary E Platek, Song Yao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2015
Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention TrialTeemu J Murtola, Bora Gurel, Martin Umbehr, et al.
The Journal of Urology|October 19, 2010
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trialDouglas K Price, Cindy H Chau, Cathee Till, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2012
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasterideAlan R Kristal, Cathee Till, Catherine M Tangen, et al.
Pageof 16